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ABSTRACT
The chicken anemia virus (CAV) Apoptin can induce apoptosis specifically in tumor cells and not in
normal cells. Therefore, this shows a promising use for cancer gene therapy in the future. However, the
mechanism of apoptin-induced apoptosis in tumor cells has not been well characterized. We tried to construct
p-Ec-Apo (Apoptin expression plasmid for Escherichia coli) for further use, especially to explore the molecular
aspect and therapeutically strategy of Apoptin. Aim of this study is to construct plasmid for expression of
Apoptin in Escherichia coli. A complete open reading frame of the Apoptin gene of CAV/wild type was
amplified by PCR. The PCR product was then purified from the agarose using QIAquick Gel Extraction Kit
(Qiagen), subcloned into the respective sites of pETBlue-1 (Novagen). The molecular clone was transformed
into Escherichia coli, purified, and sequenced. The nucleotide sequence was analyzed by CLC Main Workbench
(CLC Bio). Results: The clone thus obtained, p-Ec-Apo, was successfully constructed.
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INTRODUCTION
Apoptin is a protein that was originally identified from chicken anaemia virus (CAV), a
virus from Gyrovirus genus, contains about 121 amino acid with 13.6 kD in weight. Apoptin
induces apoptosis specifically in tumour and transformed cells but not in normal cells. It
resides in the cytoplasm of normal cells, but in cancer cells translocates into the nucleus
(Peng et al., 2013). Apoptin-induced apoptosis has implicated various mechanisms. The
mechanisms that are known such p53-independent pathway, inducing cell cycle G2/M phase
arrest, and causing the nuclear accumulation of survival kinases. Therefore, apoptin promis-
ing for cancer gene theraphy in the future. However, other mechanism of Apoptin-induced
apoptosis has not yet been well characterized, especially the mechanism of apoptosis that
why without any side effects in normal cells. Last study reported that CDK1 may interacts
with apoptin to modulate apoptosis in cancer (Zhao et al., 2013). It indicates that cellular
signaling has implicate apoptin-induced apoptosis and this pathway has not yet been well
studied. Using plasmid effector is very useful to develop apoptin as gene theraphy and to
delineate mechanism of apoptin-induced apoptosis. To maximize expression of Apoptin,
we sought to use plasmid effector which be suitable for Apoptin gene expression and that
replicate at a high copy number. Therefore, we choose pETBlue-1 which be suitable for
many application and its has high copy number (Novagen). In this study, we tried to construct
p-Ec-Apo (Apoptin expression plasmid for Escherichia coli) for further use, especially to
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explore the molecular aspect and therapeutically strategy of Apoptin.
MATERIALS AND METHODS
To construct an Apoptin expression plasmid, a complete open reading frame of the
Apoptin gene of CAV/wild type (Prasetyo et al., 2009) was directly cloned by PCR using
Accuprime Pfx DNA Polymerase (Invitrogen, Carlsbad, CA). The PCR product was checked
by electrophoresis agarose, and then purified from agarose using QIAquick Gel Extraction
Kit (Qiagen, Hilden, Germany). The PCR product was then ligated into the respective sites
of pETBlue-1 (Novagen Darmstadt, Germany). The molecular clone then was transformed
into NovaBlue Singles™ Competent Cells (Escherichia coli) by heat shock, followed by
carbenicillin resistant selection. Prior to growing colonies for plasmid isolation, the pres-
ence of the appropriate insert and its orientation was determined using direct colony PCR
and restriction enzyme analyzed. After positive clones were identified, high-copy plasmids
were isolated for transformation, restriction mapping, and sequence analysis. The sequenc-
ing step was performed in both orientations for confirmation, three times for each orienta-
tion. The nucleotide sequence was analyzed by CLC Main Workbench (CLC Bio).
RESULTS AND DISCUSSION
The mechanism apoptosis induced by Apoptin usually using Apoptin expression plas-
mid or Apoptin recombinant viral vector, mostly Adenovirus, for the best of our knowledge.
For example, to rule out dependency of Apoptin to Bcl-2 and Bcl-xL proteins and the p53
pathway, was explored using human adenovirus vector (Li et al., 2013). A study explored the
expression profiles of tumor-associated genes altered by Apoptin have also been done us-
ing Adenovirus vector (Wang et al., 2013). Other viral vector (e.g. lentiviral) was also re-
ported been used (Ma et al., 2012). Eukaryotic Apoptin expression plasmid was also been
used as tool to study the apoptosis induced by Apoptin (Zhan et al., 2012). Another strategy
to study about Apoptin is using Apoptin-tagged with flag. For example, to explore the local-
ization mechanism of Apoptin in human HepG2 tumor cell lines, the purified prokaryotic na-
tive His-apoptin was used as bait for capturing Apoptin-associated proteins (Peng et al.,
2013). However, the data resulted from all strategy described previously may influenced by
the vector and or tag used in the study. One may argue, that the best data to understanding
the apoptosis mechanism of Apoptin in the cells should derived from “a pure Apoptin protein
delivering into cells” experiments. To do so, adequate quality and quantity of Apoptin will be
needed. Therefore, we tried to construct Escherichia coli expression plasmid for tumor re-
search and or therapeutic applications. Efficient production of an engineered Apoptin in a
recombinant Escherichia coli have been reported previously, however, the Apoptin was
flagged with GST tag (Lee et al., 2012).
In results, an Apoptin recombinant plasmid to express wild type of Apoptin in Escheri-
chia coli expression system, namely as p-Ec-Apo, was successfully constructed. The plas-
mid expressor, pETBlue-1, has T7lac promoter and its originated from pET plasmid expressor
which has high copy number. pET was included in best-developed class of plasmid vectors
for many manipulations is based on the colicin E1 (ColE) replicon. In other yield, pUC origin
of replication in pETBlue-1 provides an advantage for plasmid manipulation. It may be very
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benefically for p-Ec-Apo because it has high copy number and providing other plasmid
manipulation. Plasmid manipulation may contribute in apoptin modification which helpful to
delineate mechanism of Apoptin-induced apoptosis and to explore the molecular aspect of
Apoptin. In conclusion, p-Ec-Apo was successfully constructed which originated from pETBlue-
1 that has high copy number and its has advantages in plasmid manipulation.
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